Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
.11 and Up!
»
ACTC--I LIKE IT NOW!!
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by IMAKEMONEY: [QB] Advanced Cell Technology, Inc. Mid-Quarter Review Issued by Scimitar Equity Research, Inc. May 8, 2007 09:39:00 (ET) BOSTON, May 8, 2007 /PRNewswire via COMTEX/ -- Scimitar Equity Research, Inc. today issued aQ4/06 Analyst Review on Advanced Cell Technology, Inc. (ACTC, Trade ) entitled, "'Hemangioblast' Precursor Cells Produced From Human Embryonic Stem Cells Show Remarkable Ability to Repair Vascular Damage in Animals". Advanced Cell Technology (ACT) is a biotechnology company applying human embryonic stem (hES) cell technology in the emerging field of regenerative medicine. ACT is developing novel stem cell-based treatments and cures to target a variety of serious diseases and injuries. ACTC's lead therapeutic development programs include stem cell based treatments for retinal disease such as macular degeneration; diseases of the blood, heart and circulatory system, and dermatological treatments for repair of skin damage from surgery, wounds and burns. ACT has entered development partnerships with leading institutions, and is pursuing additional partnerships with leading biotechnology companies and organizations worldwide. The analyst research review of ACTC is available on Scimitar's website: [URL=http://www.scimitarequity.com]www.scimitarequity.com[/URL] . About Advanced Cell Technology, Inc. Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information, please visit: [URL=http://www.advancedcell.com]www.advancedcell.com[/URL] . For investor-specific information and resources, visit http://www.trilogy-capital.com/tcp/advanced_cell . To read or download Advanced Cell's Investor Fact Sheet, please visit http://www.trilogy-capital.com/tcp/advanced_cell/factsheet.html . To view recent stock quotes and news, visit http://www.trilogy-capital.com/tcp/advanced_cell/quote.html . Scimitar Equity Research, Inc. provides sponsored equity research of the healthcare industry for the institutional and investment communities. We certify that all the views expressed in this review, accurately reflect our personal views about Advanced Cell Technology (ACTC, Trade ) and its or their securities. No part of our compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views contained in this review and we will not have any investment banking relationships or personal investment in any sponsored company. Investors are advised that this analysis and review is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. Scimitar was paid for preparing this review. This analysis and review does not have regard to the specific investment objectives, financial situation and the information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate. Any opinions expressed are statements of our own judgment as of the date of publication and are subject to change without notice. Please read all our important disclosures. CONTACT: Scimitar Equity Research, Inc. Henry W. McCusker Director of Research phone: (617) 559-1080 fax: (617) 559-1083 e-mail: hwm*scimitarequity.com SOURCE Scimitar Equity Research, Inc. Henry W. McCusker, Director of Research for Scimitar Equity Research, Inc., +1-617-559-1080, +1-617-559-1083 (fax), hwm*scimitarequity.com http://www.scimitarequity.com [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2